Zevra Therapeutics (ZVRA) EBT Margin (2019 - 2026)
Zevra Therapeutics' EBT Margin was 32.23% in Q2 2026, down 264.71 percentage points from 296.93% a year earlier and down 91.47 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBT Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zevra Therapeutics' EBT Margin was 50.88% through Jun 30, 2026, up 16.38 percentage points year-over-year; for FY2025, it was 81.39%, up 463.14 percentage points from FY2024.
- EBT Margin shows a five-year change of +177.72 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -381.76% in FY2024 (-214.07 pp), -167.69% in FY2023 (+96.11 pp), -263.80% in FY2022 (-234.06 pp) and -29.74% in FY2021 (+66.59 pp).
- Quarterly EBT Margin has moved between -1904.38% (Q2 2022) and 319.93% (Q4 2022) over five years.
- Compared with a year earlier, EBT Margin was higher in five of the last eight quarters, with an average year-over-year change of +203.61 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q2 2023 (a gain of 1873.13 percentage points); the worst was Q2 2022 (a drop of 1956.14 percentage points).
- Per Business Quant data, ZVRA's EBT Margin in the three quarters before Q2 2026 was 123.70% (Q1 2026), 37.08% (Q4 2025) and -3.74% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 32.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.23% |
| Mar 31, 2026 | 123.70% |
| Dec 31, 2025 | 37.08% |
| Sep 30, 2025 | -3.74% |
| Jun 30, 2025 | 296.93% |
| Mar 31, 2025 | -9.40% |
| Dec 31, 2024 | -169.56% |
| Sep 30, 2024 | -897.97% |
| Jun 30, 2024 | -446.28% |
| Mar 31, 2024 | -487.36% |
| Dec 31, 2023 | -153.96% |
| Sep 30, 2023 | -351.99% |
| Jun 30, 2023 | -31.25% |
| Mar 31, 2023 | -419.40% |
| Dec 31, 2022 | 319.93% |
| Sep 30, 2022 | -231.35% |
| Jun 30, 2022 | -1,904.38% |
| Mar 31, 2022 | -47.11% |
| Dec 31, 2021 | -103.37% |
| Sep 30, 2021 | -89.52% |
API Access
Zevra Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();